The prevalence of cardiovascular disease in Ethiopia: a systematic review and meta-analysis of institutional and community-based studies

Abstract

Background Worldwide cardiovascular disease is the major cause of disability and premature death. This is due to the ascending trend of consuming an unhealthy diet and obesity which increases the risk of hypertension and type 2 diabetes mellitus. Thus this study aimed to determine the pooled prevalence of the cardiovascular disease in Ethiopia. Methods Medline, Scopus, and Google Scholar search engines were accessed using medical subject heading (MeSH) terms for studies based in Ethiopia, from 2000 to 2018. However, studies done among a specific group of the population were excluded from the study. Data were extracted by one reviewer and then checked independently by a second reviewer. Studies were qualitatively synthesis in terms of design, quality, study population, outcomes, and result. Sub-group analysis and sensitivity tests were conducted to identify potential influences on the prevalence estimates. Quantitative results were pooled in a statistical meta-analysis using STATA version 14 software. Result Nine eligible cross-sectional studies were included in the analysis. The prevalence ranges from 1 to 20%. The pooled prevalence of cardiovascular disease (CVD) was 5% (95% CI: 3–8%). The prevalence was higher in the population who visits hospitals, 8% (95% CI: 4–12%) compared to the general population, 2% (95% CI: 1–5%). There was no significant difference in the overall prevalence of CVD between males and females. Conclusion The prevalence of cardiovascular disease was high. A higher prevalence of CVD was found among patients who visited health institutions than the general population and no observed significant sex difference in the prevalence

Multicenter Cross-Sectional Study on Perceptions and Roles of Community Pharmacists in the Prevention and Management of Cardiovascular Disorders in Northwest Ethiopia

“… 2 A systematic review and meta-analysis study conducted in Ethiopia reported that the prevalence of CVDs was ranged from 1–20% with a pooled prevalence of 5% and higher in the population who visited hospitals 8%. 3 …”

“…2 A systematic review and meta-analysis study conducted in Ethiopia reported that the prevalence of CVDs was ranged from 1-20% with a pooled prevalence of 5% and higher in the population who visited hospitals 8%. 3 The surge in the occurrence of CV disorders has been linked to various reasons. The disorders are strongly accompanied by the peoples' lifestyle and several physiological aspects that could be ever-changing.…”

Medication Appropriateness, Polypharmacy, and Drug-Drug Interactions in Ambulatory Elderly Patients with Cardiovascular Diseases at Tikur Anbessa Specialized Hospital, Ethiopia

“…In Ethiopia, the pooled prevalence of CVD was 5% (1–20%) in the general population, 19 but its prevalence is expected to be higher in the elderly population. Despite CVD is the leading cause of death and disability among the elderly, 20 data are scarce regarding the appropriate use of medication in Tikur Anbessa Specialized Hospital (TASH).…”

Platelet‐rich plasma exhibits anti‐inflammatory effect and attenuates cardiomyocyte damage by reducing NF‐κB and enhancing VEGF expression in isoproterenol induced cardiotoxicity model

“…Cardiovascular diseases (CVDs) are the leading cause of disability and premature deaths throughout the world, accounting total of 46% premature deaths worldwide. 1 CVDs are a group of disorders of the heart and blood vessels and include conditions like coronary heart disease, stroke and rheumatic heart disease. 2 The sympathetic nervous system (SNS) regulates a variety of cardiovascular actions including heart rate acceleration, cardiac contractility, reduction of venous capacitance, and constriction of resistance vessels.…”